IVF Treatment

A growing number of young women are experiencing hormonal imbalance and fertility-related issues much earlier than previously seen, with experts attributing the trend to a combination of biological shifts and modern lifestyle factors. Doctors say there is a noticeable change in clinical patterns, with conditions once common in women in their late 30s now increasingly being diagnosed in those in their 20s. "There is a clear and concerning shift in women's health today, where issues related to hormonal imbalance and fertility are appearing much earlier than we traditionally observed," Priti Arora Dhamija, senior consultant and lead IVF, gynaecology at the Sitaram Bhartia Institute of Science and Research, said. She noted that one contributing factor is the earlier onset of puberty. "One of the key reasons is the earlier onset of puberty with many girls now attain menarche as early as 8-9 years, which can lead to a relatively earlier decline in ovarian reserve," she said. Studies ...

Regulator flags rise in unlicensed IVF device sales as smaller fertility centres turn to cheaper alternatives amid pricing pressures and lack of awareness

Ahead of its IPO, Gaudium IVF raised 49.5 crore by allocating 6.26 million shares to four anchor investors on February 19

The unlisted shares of Gaudium IVF were trading at ₹91 in the grey market, commanding a premium of ₹12 or 15 per cent from the upper end price of ₹79

Gaudium IVF IPO comprises a fresh issue of 11.3 million equity shares worth up to ₹90 crore and an OFS of up to 9.49 million equity shares worth up to ₹75 crore

Employee attrition, according to the RHP, stood at 31 per cent for the period ended September 30, 2025, following elevated levels of 63 per cent in FY25 and 51 per cent each in FY24 and FY23

Intas has signed an exclusive agreement with SII-backed IntegriMedical to deploy needle-free injection systems across IVF clinics, targeting an all-India rollout by Q1FY26.

Pavel Durov so far has six children from three partners and has more than 100 other children in 12 countries through sperm donation

From age-related decline to pollution, stress and medical treatments, experts explain why sperm freezing is becoming an increasingly sensible choice for modern men

Is infertility only a woman’s issue? Do stress, supplements, or sex positions improve fertility? In this episode of our fact-check series, we debunk the most common myths about infertility, IVF

From sperm count and irregular periods to IVF and birth control pills, fertility doctors explain the misconceptions that add stigma, delay treatment, and fuel anxiety for couples trying to conceive

The company raised the funds at a valuation of Rs 1,000 crore, which will help it expand its network of fertility specialists, invest in technology, and deepen clinical capabilities

Indian IVF providers are deploying AI for embryo and sperm selection to improve precision, reduce costs, and widen fertility access amid growing demand for reproductive care

As more couples turn to IVF for parenthood, understanding the step-by-step process, costs and success rates is key to navigating this complex journey

Rising infertility, delayed motherhood and increased awareness are driving demand for egg freezing across India, with clinics reporting a surge in inquiries from urban women

As infertility rates climb and fertility rates fall, IVF and embryologists continue to offer millions the promise of parenthood

The breakthrough could prevent inherited diseases, but raises ethical concerns around access and genetic enhancement

Fertility services provider Indira IVF Hospital Ltd has confidentially filed draft papers with markets regulator Sebi to raise funds through an initial public offering (IPO), according to a public announcement on Wednesday. The development comes amidst growing investor interest in the Indian assisted reproductive technology (ART) sector, buoyed by increasing awareness, expanding market size, and favourable demographics. In a public announcement, Indira IVF stated that it has submitted "the pre-filed draft red herring prospectus with Sebi and the stock exchanges... in relation to the proposed initial public offering of its equity shares on the main board of the stock exchanges." The confidential pre-filing route allows the company to withhold public disclosure of details under the draft red herring prospectus (DRHP). Further, pre-filing DRHP does not guarantee the company will go ahead with the initial public offering (IPO). Meanwhile, market sources said Gaudium IVF and Women Healt

With India's fertility rate below replacement level, major IVF providers are moving into Tier 2 and 3 cities to meet rising demand and boost access to fertility services

Fact-check Friday: Delaying motherhood? Experts bust common myths about IVF success after 40 and explain what really affects your chances of pregnancy